Luitpold Pharmaceuticals, Inc.
Luitpold Pharmaceuticals, Inc. appears in FDA public data with 2 recalls, 2 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1421-2012, Class II) was initiated on April 24, 2012. Its most recent 510(k) clearance was granted on September 29, 2011.
Summary
- Total Recalls
- 2
- 510(k) Clearances
- 2
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1421-2012 | Class II | Epinephrine Injection, USP, 1:1000 (1 mg/mL), 25 x 1 mL Ampules, For SC and IM Use, For IV and IC Us | April 24, 2012 |
| D-1378-2012 | Class II | CONCENTRATED SODIUM CHLORIDE INJECTION, USP, 23.4% a) 30 mL SINGLE DOSE VIAL, (NDC 0517-2930-25), | March 15, 2011 |